KLRS Competitors & Alternatives
Compare Kalaris Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
KLRS
Main Stock$1.90
Tradestie Score
43
Market Cap
$113.52M
Analyst Upside
+889.5%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.76
|
$199.71M | - | 41 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.00
|
$154.27M | - | 48 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.25
|
$133.50M | - | 29 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.88
|
$117.07M | - | 30 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.15
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.78
|
$97.42M | - | 33 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 41 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.66
|
$67.94M | - | 46 | Compare |
More KLRS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry